Efficacy and safety of hyaluronic acid in knee osteoarthritis

Osteoarthritis (OA) is one of the leading causes of disability in the elderly. Changes in the lubricating properties of synovial fluid leads to significant pain and functional disability.

Osteoporosis: Link between bone and gut health

Gastrointestinal diseases (GIDs) are known risk factors of secondary osteoporosis and osteopaenia. These patients, being at increased risk of fracture, are affected at a much younger age than is normally associated with osteoporosis and warrant special consideration.1

The challenge in monitoring osteoporosis therapy

This article will examine the topics of monitoring treatment of osteoporosis (based on a presentation by Dr Graham Ellis), and fracture liaison services in South Africa, presented by Dr Hayley de Wet.

Clinical management of osteoporosis

At the NOFSA congress, Dr Mike Davey presented on non-pharmacologic oestrogen and SERMs while Drs Stan Lipschitz and Sue Brown discussed pharmacologic treatment. The following article is based on these talks.

Not all bones are equal

The following article is based on presentations by Dr Tobie de Villiers at the recent National Osteoporosis Foundation of South Africa (NOFSA) presentation of the International Society of Clinical Densitometry (ISCD) course on bone densitometry, held in Stellenbosch.

New guideline answers important questions about osteoporosis treatment

Postmenopausal osteoporosis is common in men and women over the age of 50. In fact, one in three women and one in five men in this age category are at risk of an osteoporotic fracture, according to the International Osteoporosis Foundation (IOF).

Read More
CPD POINTS: 1

Is effectiveness of hyaluronans dependent on molecular weight?

Osteoarthritis (OA) is one of the leading causes of disability in the elderly. Changes in the lubricating properties of synovial fluid lead to significant pain and functional disability.

Read More
CPD POINTS: 3

What you missed at the WCO congress

More than 4 000 delegates descended on the City of Lights from 4-7 April to attend this year’s World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.

Getting a grip on gout

Physicians still underestimate the impact of untreated gout and do not view it as a disease that has a severe impact on patients’ quality of life.

Ferrari weighs in on the management of fragility fractures

This article is based on a presentation by Prof Sergei Ferrari, chair of the Council of Scientific Advisors of the International Osteoporosis Foundation (IOF).

Distal radius fractures in the elderly

Osteoporotic fractures are emerging as a major public health problem in the ageing population. Fractures result in increased morbidity, mortality and health expenditures.

Fracture risk prediction, prevention and treatment

SPECIALIST FORUM NOVEMBER CPD 2 of 2: How effective are fracture risk tools? When should treatment be started in patients with osteoporosis? What treatment strategies are recommended and what is the role of supplementation?

Osteoarthritis pain, joint function and QoL

MEDICAL CHRONICLE NOVEMBER CPD 3 of 3: Chronic diseases of the musculoskeletal system are among the most prevalent health hazards in the world’s population.

Prioritising osteoporosis

MEDICAL CHRONICLE SEPTEMBER CPD 1 of 5: Awareness of the consequences of osteoporosis and fragility fractures should be a South African priority.

Efficacy and safety of intra-articular use of hyaluronic acid in the treatment of knee osteoarthritis

MEDICAL CHRONICLE AUGUST CPD 4 of 4: Hyaluronic acid reduces the symptoms and development of osteoarthritis.

Etoricoxib most cost-effective initial NSAID treatment

SPECIALIST FORUM AUGUST CPD 4 of 4: NSAIDs are the mainstay treatment of osteoarthritis and rheumatoid arthritis, two of the leading causes of morbidity and disability worldwide.

Track the crack

SPECIALIST FORUM AUGUST CPD 2 of 4: The increase in fragility fractures worldwide has been described as a ‘silver tsunami’ and is exacerbated by a lack of treatment delivery.